Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The delicacy, long a feature on the menu of gourmet restaurants across the globe, is made by force-feeding geese to turn their livers to fat, a process long denounced as cruel by animal rights activists and increasingly viewed with unease by authorities in some western cities. In October, New York City, often considered the U.S. fine dining capital, prohibited the sale of foie gras, following similar bans in Chicago and the state of California. In response, French scientists at research company Aviwell near Toulouse have developed an alternative version of the delicacy that uses bacteria - ingested by the goose as a serum - to stimulate a natural, rather than forced, build-up of fat. “It’s the combination of certain bacteria that is capable of triggering in baby geese the natural composition, and completely biological growth, of fat in the liver,” company co-founder Remy Burcelin said. Aviwell raised 600 geese when it launched its project last year, and Fosserie has now become the first foie gras farmer to adopt the technique, which also doubles the birds’ average lifespan from three to six months. “It’s the future, because we see the animal welfare movement getting bigger and bigger,” she said. This next-generation foie gras will be aimed primarily at the U.S. market and Europe, where Britain, Finland and Poland have banned its production. But the French culinary establishment is taking note too. Toulouse chef Simon Carlier, who has been creating dishes with Aviwell’s foie gras for a month, described it as subtle and with an appealing density. It could be served cold or just with little garnishing. “We see a texture, which is less nauseating, let’s say. We can’t compare it to meat - but in some way, it’s easier to eat,” Carlier said. It will also be more expensive. While high-quality traditional foie gras sells for about 300 to 400 euros  ($330-440) per kilo (2.2 lb), Aviwell’s version could fetch 1,000 euros. A naturally fatty goose liver weighs 300-400 grammas while that of a force-fed goose can weigh around 1 kg.
[A]: Force-feeding off menu as France trials 'naturally fatty' foie gras.


[Q]: That’s the advice to care givers from a consortium of nutritional researchers following a two-year survey of what U.S. cancer patients prefer to eat and drink. The study released on Tuesday by the Cancer Nutrition Consortium aims to improve the lives of cancer patients by helping them get the meals they want while combating the weight loss and fatigue that often comes with aggressive treatment. Researchers surveyed 1,203 patients at seven of the world’s leading cancer centers, including Dana-Farber and the Mayo Clinic, and found 40 percent developed more sensitive palates after starting treatments like chemotherapy and radiation. Some 52 percent of the surveyed patients said they were avoiding greasy or fried foods, 44 percent said they were avoiding spicy foods, and nearly a third said they were avoiding acidic foods like grapefruit. Most patients cited intolerance, while less than half said they were acting on the advice of doctors. Some 69 percent of patients said they preferred fruits and vegetables, around 60 percent favored soups and poultry, and more than half said they liked pasta and fish, according to the research. “Typically the patients ran for the healthier foods. But there were exceptions, and it is important to keep in mind that it is not one size fits all,” said Kathy McManus, director of nutrition at Dana-Farber. The study also showed most patients staying away from beverages like beer, wine and soda, while gravitating toward healthier options like water and fruit juice. “Many of our patients suffer from problems getting adequate nutrition through treatment, and some of them are unsure about what they should be eating,” said Terry Langbaum, chief operating officer for Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which also participated in the study. “This research study involved the patients and truly helped us to better understand preferences,” he said. The study was underwritten by Jeremy Jacobs, chairman and CEO of global food and hospitality service provider Delaware North Companies, and conducted by marketing firm WHP Research. The research recommends care givers develop recipes, prepared foods and menus that are tailored to the preferences of cancer patients, but is not intended to advance Delaware North’s business, WHP President Wendy Price said. The Cancer Nutrition Consortium said it was launching a website that includes recipes designed by chefs and tailored to the findings of the survey. The bottom line for hospital kitchens putting together their menus in the oncology ward: “Limit greasy and fried food offerings since about one-half of patients are avoiding these types of foods,” according to the study.
[A]: Broccoli not burgers: Cancer patients favor healthier foods.


[Q]: A senior administration official outlined the plan Thursday on condition of anonymity ahead of the release of Trump’s 2019 budget plan next week. Pharmaceutical companies now pay rebates to insurers and pharmacy benefit managers to help their medications gain a bigger slice of the market. Insurers apply savings from rebates to keep premiums more manageable. Under Trump’s proposal, seniors covered by Medicare’s popular “Part D” prescription benefit would be able to share in the rebates for individual drugs that they purchase at the pharmacy. Trump’s budget would also expand Medicare’s “catastrophic” drug benefit so that many seniors with very high costs would not face copayments. Seniors with high drug bills are currently still responsible for 5 percent of the cost of their medications. With some new drugs costing $100,000 a year or more, patient costs add up quickly. The White House proposal would put Trump in the middle of a tug-of-war between drug companies on one side and insurers and pharmacy benefit managers on the other, with billions of dollars at stake. Insurers and pharmacy benefit managers say the reason drug costs are so high is that drug companies are free to charge what the market will bear. The pharmaceutical industry says middlemen are the problem, because they keep rebates paid by drug makers instead of passing them on to patients. Insurers counter that rebates are passed on in the form of lower monthly premiums for everybody. The drug industry lobbying group, Pharmaceutical Research and Manufacturers of America, had no immediate reaction. The Trump administration’s new proposals come on top of a long list of Medicare changes in the congressional budget deal. Medicare is the government’s premier health insurance program, covering about 60 million seniors and disabled people. Lawmakers would shift a greater share of Medicare drug costs to the pharmaceutical industry. They also want to eliminate the drug coverage gap known as the “doughnut hole” one year earlier than currently scheduled, in 2019 instead of 2020. “On the whole, I think this is a good bill for people with Medicare,” said Joe Baker, president of the Medicare Rights Center, said of the congressional legislation. “This tilts toward getting a lot of good things done.” But his group opposes a provision that would raise premiums paid by the wealthiest retirees for coverage of outpatient services and prescription drugs. Here’s a look at some of the major Medicare provisions in the budget deal that Republican leaders are trying to push through Congress. Democrats are split over the overall measure, but the Medicare provisions appear to have support from both parties: — PRESCRIPTION DRUGS Originally, beneficiaries in the “doughnut hole” coverage gap were responsible for the full cost of their medications, but the Affordable Care Act passed under former President Barack Obama gradually closes the gap. The budget deal accelerates the timetable by one year, to 2019. Drug makers are already required to provide discounts to close the coverage gap, but the budget deal raises the level of company discounts, which in turn lowers the government’s costs. That should act as a brake on the monthly premiums paid by beneficiaries. “In theory when Medicare spending goes down, premiums would go down, too,” said Tricia Neuman, a Medicare expert with the nonpartisan Kaiser Family Foundation. The drug industry is criticizing the proposal, saying it will mainly benefit insurance companies that act as middlemen providing the benefit. The coverage gap starts when beneficiaries hit $3,750 in total drug costs. — CAPS REPEALED ON REHAB The budget deal permanently repeals limits on therapy services commonly used by stroke patients and people recovering from major surgeries. Those services include physical therapy, occupational therapy and speech therapy. In previous years, Congress had routinely held off on applying the caps. Groups including AARP were pressing for a full repeal. It takes effect this year. __HIGHER PREMIUMS FOR WEALTHIEST RETIREES Premiums for outpatient coverage and prescription drugs would rise for about 1 million wealthy seniors with annual incomes of at least $500,000 for an individual, or $750,000 for a couple filing jointly. Hiking premiums on the well-to-do is an idea that has bipartisan support among lawmakers, but advocates worry that Congress will ultimately start raising costs for middle-class seniors as well. __TELEMEDICINE AND CHRONIC CARE The budget deal expands Medicare’s ability to pay for telemedicine in a wide variety of situations, including for patients with stroke symptoms. It also incorporates a bipartisan Senate bill that is intended to improve care coordination for patients with chronic illnesses, such as heart disease, cancer, and diabetes. —COST CONTROL BOARD REPEALED The deal would repeal the Independent Payment Advisory Board, a Medicare cost-control agency authorized under the Affordable Care Act. It was controversial from the beginning, and the Obama White House did not move forward to set up the board.
[A]:
Trump proposes reduction of drug costs under Medicare.